Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma

BACKGROUND: In view of the fact that peripheral blood parameters have been reported as predictors of immunotherapy to various cancers, this study aimed to determine the predictors of response to anti-programmed death-1 (anti-PD-1) therapy in patients with esophageal squamous cell carcinoma (ESCC) fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xianbin, Han, Runkun, Zhong, Yanping, Weng, Nuoqing, Zhang, Ao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262036/
https://www.ncbi.nlm.nih.gov/pubmed/34233686
http://dx.doi.org/10.1186/s12935-021-02072-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262036/
https://www.ncbi.nlm.nih.gov/pubmed/34233686
http://dx.doi.org/10.1186/s12935-021-02072-x

Ejemplares similares